Amit Sachdev
EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc / Ma (VRTX)
Amit Sachdev has filed 39 insider reports with the SEC since February 2021, as EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc / Ma (VRTX) and director at Eiger BioPharmaceuticals, Inc. (EIGR). In the last 12 months Amit Sachdev sold $28.4M of stock on the open market. The latest filing, on July 23, 2026, reports grant or award at Vertex Pharmaceuticals Inc / Ma (VRTX).
- Filings
- 39
- Companies
- 2
- Bought on market
- None
- Sold on market
- $42.2M
Companies where Amit Sachdev is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| EVP Chief Patient & Ext Af Off | 66,512 | $42.2M | $547.89 | Jul 23, 2026 | |||
| Director | 16,000 | Mar 12, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 21, 2026VRTXEVP Chief Patient & Ext Af Off Sachdev Amit was granted 8,251 shares, increasing direct ownership by 14% to 66,512 unitsForm 4Grant or award
- Feb 25, 2026-$898KVRTXEVP Chief Patient & Ext Af Off Sachdev Amit covered exercise/tax liability with 1,518 shares and sold $897,802 worth of shares (1,846 units at $486.35), decreasing direct ownership by 6% to 55,570 unitsForm 4Shares withheld for taxes or exercise priceOpen-market sale10b5-1 plan
- Feb 19, 2026-$27.5MVRTXEVP Chief Patient & Ext Af Off Sachdev Amit exercised 48,505 shares at a strike of $172.06 and sold $27,479,583 worth of shares (58,613 units at $468.83), decreasing direct ownership by 15% to 58,934 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 17, 2026VRTXEVP Chief Patient & Ext Af Off Sachdev Amit was granted 5,789 shares and covered exercise/tax liability with 2,140 shares, increasing direct ownership by 6% to 69,042 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 13, 2026VRTXEVP Chief Patient & Ext Af Off Sachdev Amit covered exercise/tax liability with 3,548 shares, decreasing direct ownership by 5% to 65,393 unitsForm 4Shares withheld for taxes or exercise price
- Feb 10, 2026VRTXEVP Chief Patient & Ext Af Off Sachdev Amit covered exercise/tax liability with 2,057 shares, decreasing direct ownership by 3% to 68,941 unitsForm 4Shares withheld for taxes or exercise price
- Jan 22, 2026VRTXEVP Chief Patient & Ext Af Off Sachdev Amit was granted 11,749 shares, increasing direct ownership by 20% to 70,998 unitsForm 4Grant or award
- Feb 26, 2025VRTXEVP Chief Patient & Ext Af Off Sachdev Amit covered exercise/tax liability with 3,703 shares, decreasing direct ownership by 5% to 68,490 unitsForm 4Shares withheld for taxes or exercise price
- Feb 24, 2025VRTXEVP Chief Patient & Ext Af Off Sachdev Amit covered exercise/tax liability with 2,470 shares, decreasing direct ownership by 3% to 72,193 unitsForm 4Shares withheld for taxes or exercise price
- Feb 14, 2025VRTXEVP Chief Patient & Ext Af Off Sachdev Amit covered exercise/tax liability with 2,139 shares, decreasing direct ownership by 3% to 74,663 unitsForm 4Shares withheld for taxes or exercise price
- Feb 12, 2025VRTXEVP Chief Patient & Ext Af Off Sachdev Amit was granted 6,211 shares, increasing direct ownership by 9% to 76,802 unitsForm 4Grant or award
- Feb 10, 2025VRTXEVP Chief Patient & Ext Af Off Sachdev Amit covered exercise/tax liability with 2,056 shares, decreasing direct ownership by 3% to 70,591 unitsForm 4Shares withheld for taxes or exercise price
- Feb 4, 2025VRTXEVP Chief Patient & Ext Af Off Sachdev Amit was granted 15,324 shares, increasing direct ownership by 27% to 72,647 unitsForm 4Grant or award
- Jun 5, 2024VRTXSachdev Amit gifted 4,600 sharesForm 4Gift
- May 15, 2024-$13.8KVRTXSachdev Amit sold $13,790 worth of shares (32 units at $430.93), decreasing direct ownership by 0.06% to 55,325 unitsForm 4Open-market sale10b5-1 plan
- Feb 26, 2024-$1.28MVRTXSachdev Amit covered exercise/tax liability with 2,469 shares and sold $1,278,803 worth of shares (3,004 units at $425.70), decreasing direct ownership by 9% to 55,325 unitsForm 4Shares withheld for taxes or exercise priceOpen-market sale10b5-1 plan
- Feb 21, 2024-$1.35MVRTXSachdev Amit sold $1,345,868 worth of shares (3,191 units at $421.77), decreasing direct ownership by 5% to 60,798 unitsForm 4Open-market sale10b5-1 plan
- Feb 20, 2024-$1.79MVRTXSachdev Amit sold $1,790,041 worth of shares (4,254 units at $420.79) and covered exercise/tax liability with 6,121 shares, decreasing direct ownership by 14% to 63,989 unitsForm 4Shares withheld for taxes or exercise priceOpen-market sale10b5-1 plan
- Feb 12, 2024-$1.35MVRTXSachdev Amit covered exercise/tax liability with 2,022 shares and sold $1,354,013 worth of shares (3,222 units at $420.24), decreasing direct ownership by 7% to 74,364 unitsForm 4Shares withheld for taxes or exercise priceOpen-market sale10b5-1 plan
- Feb 7, 2024VRTXSachdev Amit was granted 20,794 shares, increasing direct ownership by 35% to 79,608 unitsForm 4Grant or award
- Nov 15, 2023-$12.9KVRTXSachdev Amit sold $12,947 worth of shares (35 units at $369.92), decreasing direct ownership by 0.06% to 58,814 unitsForm 4Open-market sale10b5-1 plan
- Aug 10, 2023-$3.51MVRTXSEC Form 4: Sachdev Amit sold $3,510,850 worth of shares (10,031 units at $350.00), decreasing direct ownership by 15% to 58,814 unitsForm 4Open-market sale10b5-1 plan
- Feb 24, 2023VRTXSEC Form 4: Sachdev Amit covered exercise/tax liability with 2,468 shares, decreasing direct ownership by 4% to 66,518 unitsForm 4Shares withheld for taxes or exercise price
- Feb 17, 2023VRTXSEC Form 4: Sachdev Amit covered exercise/tax liability with 3,498 shares, decreasing direct ownership by 5% to 68,986 unitsForm 4Shares withheld for taxes or exercise price
- Feb 13, 2023VRTXSEC Form 4: Sachdev Amit covered exercise/tax liability with 7,268 shares, decreasing direct ownership by 9% to 72,484 unitsForm 4Shares withheld for taxes or exercise price
- Feb 1, 2023VRTXSEC Form 4: Sachdev Amit gifted 1,672 shares and was granted 26,400 shares, increasing direct ownership by 49% to 79,752 unitsForm 4Grant or awardGift
- Mar 11, 2022EIGRSEC Form 4: Sachdev Amit was granted 6,000 shares, increasing direct ownership by 60% to 16,000 unitsForm 4Grant or award
- Feb 24, 2022VRTXSEC Form 4: Sachdev Amit covered exercise/tax liability with 7,368 shares, decreasing direct ownership by 13% to 48,210 unitsForm 4Shares withheld for taxes or exercise price
- Feb 17, 2022VRTXSEC Form 4: Sachdev Amit covered exercise/tax liability with 3,497 shares, decreasing direct ownership by 6% to 55,578 unitsForm 4Shares withheld for taxes or exercise price
- Feb 10, 2022VRTXSEC Form 4: Sachdev Amit covered exercise/tax liability with 2,491 shares, decreasing direct ownership by 4% to 59,075 unitsForm 4Shares withheld for taxes or exercise price
- Feb 1, 2022VRTXSEC Form 4: Sachdev Amit was granted 29,638 shares, increasing direct ownership by 93% to 61,566 unitsForm 4Grant or award
- Nov 15, 2021-$9,547VRTXSEC Form 4: Sachdev Amit sold $9,547 worth of shares (51 units at $187.19) as part of a pre-agreed trading plan, decreasing direct ownership by 0.16% to 31,928 unitsForm 4Open-market sale10b5-1 plan
- Apr 27, 2021-$839KVRTXSEC Form 4: Sachdev Amit exercised 3,884 units of Common Stock at a strike of $86.52 and sold $839,193 worth of Common Stock (3,884 units at $216.06)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 12, 2021EIGRSEC Form 4: Amit Sachdev was granted 5,000 units of Common Stock, increasing direct ownership by 100% to 10,000 unitsForm 4Grant or award
- Feb 25, 2021-$765KVRTXSEC Form 4: Amit Sachdev disposed of $640,961 worth of Common Stock (2,946 units at $217.57) and sold $765,307 worth of Common Stock (3,586 units at $213.42), decreasing ownership by 14% to 40,133 unitsForm 4Shares withheld for taxes or exercise priceOpen-market sale10b5-1 plan
- Feb 18, 2021-$1.96MVRTXSEC Form 4: Amit Sachdev disposed of $1,612,053 worth of Common Stock (7,613 units at $211.75) and sold $1,962,366 worth of Common Stock (9,264 units at $211.83), decreasing ownership by 27% to 46,665 unitsForm 4Shares withheld for taxes or exercise priceOpen-market sale10b5-1 plan
- Feb 11, 2021-$939KVRTXSEC Form 4: Amit Sachdev sold $939,068 worth of Common Stock (4,460 units at $210.55), decreasing ownership by 7% to 63,542 unitsForm 4Open-market sale10b5-1 plan
- Feb 10, 2021VRTXSEC Form 4: Amit Sachdev disposed of $518,481 worth of Common Stock (2,421 units at $214.16), decreasing ownership by 3% to 68,002 unitsForm 4Shares withheld for taxes or exercise price
- Feb 3, 2021VRTXSEC Form 4: Amit Sachdev gifted 3,391 units of Common Stock and was granted 32,077 units of Common Stock, increasing ownership by 84% to 70,423 unitsForm 4Grant or awardGift
Compare Amit Sachdev with
- Amit Sachdev vs Jasper van Grunsven1 shared
- Amit Sachdev vs Kristen Ambrose1 shared
- Amit Sachdev vs Bruce I Sachs1 shared
- Amit Sachdev vs Ourania Tatsis1 shared
- Amit Sachdev vs Alan M Garber1 shared
- Amit Sachdev vs Duncan McKechnie1 shared
Other insiders at the same companies
- Reshma KewalramaniVRTX
- Jasper van GrunsvenVRTX
- Kristen AmbroseVRTX
- Bruce I SachsVRTX
- Ourania TatsisVRTX
- Alan M GarberVRTX
- Duncan McKechnieVRTX
- Joy LiuVRTX
- Carmen BozicVRTX
- Mark E. BunnageVRTX
- Suketu UpadhyayVRTX
- Nancy ThornberryVRTX
- Jennifer SchneiderVRTX
- Diana MckenzieVRTX
- Michel LagardeVRTX
- Lloyd CarneyVRTX
Questions about Amit Sachdev
- What is Amit Sachdev's role at Vertex Pharmaceuticals Inc / Ma?
- Amit Sachdev reports to the SEC as EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc / Ma (VRTX), according to the latest filing on July 23, 2026. Amit Sachdev has also filed as director at Eiger BioPharmaceuticals, Inc. (EIGR).
- How many shares does Amit Sachdev own?
- After the latest filing that states it, Amit Sachdev directly owned 66,512 shares of Vertex Pharmaceuticals Inc / Ma (VRTX) and 16,000 shares of Eiger BioPharmaceuticals, Inc. (EIGR). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Amit Sachdev bought or sold stock recently?
- The most recent open-market sale was on February 25, 2026: sold 1,846 shares of Vertex Pharmaceuticals Inc / Ma (VRTX) for $898K at an average of $486.35.
- How do I get alerts when Amit Sachdev files?
- Follow Amit Sachdev on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Amit Sachdev (SEC CIK 0001406338). Totals count each trade once, skipping amendments whose original is on file, from Feb 5, 2021 on. View on SEC EDGAR